Program Chair & Presenters


Dr. Alavi is a part-time faculty member, and an Assistant Professor of Dermatology at the University of Toronto. Dr. Alavi completed her residency in dermatology in 1998 in Iran, and in 2011 in Toronto, Canada. She also completed a 2-year fellowship in Wound Healing and a Master’s of Science in Community Health at the University of Toronto. She is the Director of the Wound Healing Fellowship at Women’s College Hospital and her research interests include wound healing, hidradenitis suppurativa, and medical dermatology.

Dr. Alavi is the past president of the Canadian Hidradenitis Suppurativa Foundation, a board member of the Canadian Dermatology Association, and an international board member of the Association for the Advancement of Wound Care (AAWC). Dr. Alavi has received multiple awards including the Colin A. Ramsay Resident Teacher Award from the University of Toronto, the Women’s Dermatology Mentorship Award and recently the practitioner of the year award from the Canadian Dermatology Association in 2017. Dr. Alavi has published extensively in peer-reviewed journals.

Wendy has been an employee of Galderma Canada Inc. for over 23 years, and has held the position as General Manager since 2008. She joined Galderma in 1995 as a Product Manager and was hired to run the flag-ship OTC brand Cetaphil and launch Differin, the first new acne molecule to be introduced to the Canadian market in over 20 years at that time. With proven success in this area, she moved through the organization holding various progressive positions in marketing, sales and management.

During her tenure at Galderma, Wendy served as an advisor to the Canadian Skin Patient Alliance, was President of the Canadian Dermatology Industry Association for over 5 years and was inducted into the Canadian Healthcare Hall of Fame in 2012.  In 2017 Wendy became a Benefactor Life member of the Canadian Dermatology Foundation.

Prior to joining Galderma, Wendy started her pharmaceutical career in the Ottawa area as a medical sales representative for Dow Pharmaceuticals. She was the sales representative of the year in 1991, and then moved into a retail role for the company before relocating to Toronto to join the marketing department. In this capacity Wendy had the fortune to manage progressively larger portfolios from Novahistex/Novahistine, Nicorette/Nicoderm to Seldane.

Wendy is a graduate of Carleton University with an Honors degree in Commerce. During her years at Carleton she was a member of the Women’s Varsity Basketball Team. Wendy is fluently bilingual (English/French).

Dr. Carroll is a board-certified dermatologist and sought-after media personality in the area of cosmetic dermatology and skin care. Dr. Carroll is a resident expert on The Global Morning Show and has appeared on The Marilyn Denis Show, ETalk, ET Canada and The Social. She is frequently quoted in major magazines including MacLean’s, Chatelaine, Elle, Canadian Living, Zoomer, Flare and Fashion. Dr. Carroll travels worldwide, both lecturing and learning, to bring the latest, cutting edge treatments to her patients. She has trained in cosmetic and laser dermatology clinics in San Diego, Los Angeles & London (UK) as well as with specialized experts from Brazil, Vancouver and Montreal.

Dr. Carroll is a Fellow of the Royal College of Physicians and Surgeons (FRCPC) and a Fellow of the American Academy of Dermatology (FAAD). Apart from her busy dermatology practice, she is also holds a teaching position within the University of Toronto, Department of Medicine.

Dr. Carroll completed her dermatology training at the University of Toronto. Prior to her dermatology training she completed medical school at Dalhousie University, graduating Alpha Omega Alpha, and also attained a Bachelor of Science in Biology from Acadia University.

Chantal is a strategic thinker and planner with a proven ability to create opportunities and deliver results. A successful mentor and leader, Chantal excels at cultivating relationships and managing people, projects and issues.

Chantal began her journey serving the healthcare community in 2000 with the Canadian Medical Association. In 2009, Chantal transitioned to the Canadian Parks and Recreation Association and in 2011, was recruited to lead the Canadian Dermatology Association (CDA).

Since then, the CDA has seen positive changes as a result of Chantal’s leadership and approach to achieving results. Throughout Chantal’s professional career, she continued her academic studies. She completed the Governance Essentials for Not-for-Profits and the Strategic Human Resource Management programs at the Rotman School of Management.

Chantal has also found time to give back to her community and has volunteered on local boards. From 2004 to 2008 she served as Chair and Spokesperson for Equal Voice, NCR. From 2007 to 2009 she served as a member of the WXN’s Ottawa Advisory Board. From 2008 to 2012 she served as a Board Trustee for CHEO. Today she serves as a member of the JC Bergeron Foundation and is Chair of the CEO Roundtable of National Medical Specialty Societies.

Marsheila DeVan is a Communication Specialist with over twenty-five years of training experience.  Her expertise includes work within university systems as well as the pharmaceutical and medical industries, concentrating on physician speaker development, interpersonal skills improvement, meeting moderation, leadership, cultural diversity, sales training, curriculum development and one-to-one coaching.

Marsheila holds a Bachelors Degree in Political Science from the University of California, Los Angeles and a Masters of Business Administration from the University of California, Irvine with a concentration in Organizational Behavior and Strategic Planning.

She spent seven years following her passion for the development of public/private partnerships between multiple communities and businesses to enhance community empowerment programs.  Her outstanding communication skills and ability to work with diverse audiences earned her multiple national awards.

Her international experience includes teaching to multiple nationalities and medical specialties in locations such as Thailand, Switzerland, Hungary, Spain, Austria, Bermuda, Australia, France, Germany, Czech Republic, Italy, Portugal, Turkey, Mexico, Canada, Korea, Hong Kong, Iraq, Iran, Pakistan, Vietnam, Philippines, Ireland, the Caribbean, Mongolia and most recently Sri Lanka.  Her extensive travels have given her an understanding of different beliefs, attitudes, and values of various cultures and people.

Marsheila’s demeanor, humor and approach to training create an open and comfortable learning environment that results in a high level of interaction and learning.

Steven Glassman

Dr. Steven Glassman completed his dermatology training at Witwatersrand University in Johannesburg, South Africa, and also spent a year of residency at New York University Medical Center under the late Dr. Irwin M. Freedberg. He worked in the Division of Dermatology in Johannesburg from 1997 to 2008, teaching medical students and residents, and also running a private practice. In 2008 he moved to Ottawa where he is Assistant Professor in the Division of Dermatology, and Director of the Phototherapy Clinic, and in July 2014 he became Program Director. Dr. Glassman has an interest in psoriasis, vitiligo and photo-medicine, and lives in the Whitehaven area with his wife Jennifer, an Educational Psychological Associate, and his son Isaac who is seventeen. His other pursuits include cycling, fishing and philately, and he enjoys classical music.

Dr. Gooderham is a Dermatologist and Medical Director at the SKiN Centre for Dermatology and an Investigator with Probity Medical Research. She is an Assistant Professor at Queen’s University and a Consultant Physician at the Peterborough Regional Health Centre. She is a fellow of the Royal College of Physicians and Surgeons of Canada. She received her MD from the University of Western Ontario in 1999, and then completed her Dermatology residency at the University of Toronto in 2004.

Dr. Gooderham lectures internationally on the topic of psoriasis and inflammatory diseases of the skin. In her clinic, she is involved in teaching medical students, residents, nurse practitioners and physicians with both didactic and clinical hands-on teaching. She practices with a focus on psoriasis, atopic dermatitis, skin cancer and clinical research.

Dr. Pearl E. Grimes is the Founder and Director of the Vitiligo and Pigmentation Institute of Southern California. She is a pioneer and a leading international authority on vitiligo and pigmentary disorders.

Dr. Grimes is a Clinical Professor of Dermatology at the David Geffen School of Medicine, University of California – Los Angeles. She has authored more than 100 professional articles, abstracts and two textbooks.

Dr. Grimes holds numerous achievements in dermatology. She has been recognized by her peers with the prestigious Dermatology Foundation “Practitioner of the Year” award and the Women’s Dermatologic Society’s “Mentor of the Year” award in 2011. She received the American Society of Dermatologic Surgery President’s Award in 2006. In 2016, she was recognized with an American Skin Association Research Achievement Award and in 2017 a Lifetime Achievement Award. She was also awarded the prestigious 2017 Arnold P. Gold Foundation Humanism in Medicine Award and the 2017 Everett C. Fox, MD Memorial Award and Lectureship.

She is also the Founder and Director of the non-profit organization, the Coalition for At-Risk Restoring Youth (CARRY). Founded in 2006, CARRY is dedicated to improving the lives of at-risk and foster care youth through a variety of innovative programs including pro bono dermatology clinics and other innovative programs that enhance self-esteem, self-worth, self-sufficiency, and long term success.

Dr. Grimes is the current President of the Women’s Dermatologic Society for 2018-2019.  She is deeply committed to the mission, core values, and growth of the WDS. She has served on multiple WDS committees, the Board of Directors, and as Vice President.

Chris Halyk was appointed President, Janssen Inc. in early 2006. Janssen is a brand name pharmaceutical company headquartered in Toronto, Canada and part of the Johnson & Johnson Family of Companies.

Mr. Halyk began his career with Johnson & Johnson when he joined Janssen Pharmaceutica Inc. in 1986 as an Over the Counter (OTC) product manager. Since then, Mr. Halyk held a number of sales and marketing roles of increasing responsibility.

In 1997, Mr. Halyk was appointed Vice-President, Sales and Marketing and a member of the Janssen Management Board. His responsibilities included innovations in direct-to-consumer advertising, patient education programs and sales force automation.

In 2001, Mr. Halyk was appointed Managing Director of Ortho Biotech, the biopharmaceutical division of Janssen Inc.

Before joining the company, Mr. Halyk worked for Warner-Lambert, a pharmaceutical company in Toronto.

Born and raised in Canada, Mr. Halyk holds an Honours Business Administration degree from the University of Western Ontario. He served as the Chair of the Board of Directors for Innovative Medicines Canada, the industry association for Canada’s Research-Based Pharmaceutical Companies from 2012 until 2013. He is married, has three children and lives in Oakville, Ontario.

Dr. Marissa Joseph graduated with a combined BSc (Honours) in Biochemistry and Biology from Dalhousie University, and then completed medical school at Dalhousie University. She is a board certified pediatrician and dermatologist after completing pediatric training at the Hospital For Sick Children, following with a dermatology residency at the University of Toronto. She completed a MSc in Community Health at the Dalla Lana School of Public Health.

Dr. Joseph is full time academic faculty at the University of Toronto and is actively involved in undergraduate and postgraduate medical education. Dr. Joseph is the Medical Director of the Ricky Kanee Schachter Dermatology Centre at Women’s College Hospital. She also works at the Hospital For Sick Children, where she manages children with complex dermatologic disease in outpatient and inpatient settings, as well as a pediatric laser treatment program. Dr. Joseph enjoys her diverse practice in general adult, pediatric, adolescent, ethnic, and surgical dermatology.

Dr. Perla Lansang is a full-time staff dermatologist and assistant professor in the Division of Dermatology, University of Toronto, where she is the director of Undergraduate Education for the Division of Dermatology.

Having done two years of fellowship in paediatric dermatology at The Hospital for Sick Children and a fellowship in medical dermatology with a special interest in psoriasis, Dr. Lansang’s practice is a mixture of pediatric, adolescent, and adult dermatology, with a special focus on psoriasis, atopic dermatitis, cutaneous lymphoma, pregnancy dermatoses, and general medical dermatology. Her practice is based at Sunnybrook Health Sciences Centre, and she also holds clinics at Women’s College Hospital-Phototherapy Education and Research Centre and The Hospital for Sick Children.

Since 2014, Stéphane Lassignardie has held the role of General Manager of AbbVie Canada.

Under his leadership, AbbVie Canada’s reputation has enhanced significantly—moved in ranking from number six to number two in the specialty pharmaceutical category, recognized among the top 50 Great Places to Work and is #2 in the PatientView (as one of the most respected companies in the eyes of patient groups) for the third year in a row.

Stéphane represents a team of over 500 professionals who are dedicated to helping people who live with many difficult to treat and chronic diseases including several auto-immune diseases such as Crohn’s disease, Psoriasis Hidradenitis Suppurativa and Rheumatoid Arthritis, hepatitis C, advanced Parkinson`s disease and CLL.

He also represents the over 80,000 Canadians who have benefitted from AbbVie Care which helps patients with such services as medication administration and adherence, disease education, and financial coverage.

AbbVie Canada has the potential to deliver more than 20 new medicines or indications by 2022. Currently, Stéphane is Director of the Board of Innovative Medicines Canada and Chair of the Quebec Core Team.

Stéphane holds a Master’s degree in Business Administration from the EMLYON Business School in France.

Janice Murray was appointed Country President, Novartis Pharmaceuticals Canada Inc. on May 1, 2017.

Ms. Murray brings with her 11 years of pharmaceutical experience. Since joining Novartis in 2006, she has held various positions of increasing responsibility in Canada and the Latin America Region. Ms. Murray held the role of Country and Pharma Chief Financial Officer (CCFO) in Canada before taking on a commercial role to lead the Ophthalmology Business Franchise in Canada. In 2014, Ms. Murray was appointed CFO of Latin America and Canada for the Pharma Division.

Prior to joining Novartis, Ms. Murray held various executive and senior level positions at Canadian National Railway & KPMG Chartered Accountants.

Ms. Murray has a Bachelor of Commerce from the University of Ottawa, a Graduate Diploma in Accountancy from McGill University, and a Chartered Accountant designation from the Ordre Des Comptables Agrées du Québec.

Ms. Murray is a member of the Board of Directors of Innovative Medicines Canada (IMC) and the Chair of IMC Atlantic Sub-Committee.

Ms. Murray is also a Board Member of the West Island Palliative Care Foundation.

Vincent Piguet, trained at the School of Medicine, University of Geneva and graduated in 1995.  He spent two years doing research in virology and immunology at the Salk Institute in San Diego, USA.  He obtained his MD and PhD (2000/2001) and his specialist certification in Dermatology & Venereology (2004) from the Swiss Medical Association. He obtained UK certification in Dermatology (2011) and in 2014 became a Fellow of the Royal College of Physicians.

In 2011 he was appointed Director of the Institute of Infection and Immunity at Cardiff University.  In 2017, he was appointed as Full Professor and Department Division Director of Dermatology, Department of Medicine, University of Toronto and Division Head of Dermatology, Women’s College Hospital, Toronto.

Professor Piguet has authored publications in the fields of dermatology and virology in top journals including Cell, Immunity, The Lancet and Journal of Investigative Dermatology.  He has received numerous grants to further his research in the areas of HIV, psoriasis, melanoma and immunology.

Dr. Claudia Posso completed her medical school and dermatology residency program in Colombia, and moved to Canada in 2011 to complete a clinical fellowship in Pediatric Dermatology at the Hospital for Sick Children in Toronto. During her two years as a clinical fellow, she developed and participated in different clinical research projects and peer-review journals.

After completing her fellowship, she worked in a community dermatology clinic in Peterborough, Ontario, where she continued to participate in research activities. She developed educational activities for medical students and health care professionals in this community. Dr. Posso is currently a third year Dermatology Resident at the University of Toronto. She received the Sunnybrook Resident (Rheumatology) Award in 2016, and the Dermatology Best Paper Award in 2016.

Among her volunteer activities, she has participated in Camp Liberté, a Canadian non-profit summer camp for children with skin diseases, supported by the Canadian Dermatology Association. She is a special advisor to the Board of Directors of Camp Liberté since 2013.

Dr. Julie Powell is a pediatrician-dermatologist and director of the Department of dermatology at the CHU Sainte-Justine University Hospital Center, in Montreal. She is also full clinical professor the University of Montreal. Dr. Powell received her medical degree from the University of Sherbrooke, where she also completed a pediatrics residency, before undertaking a dermatology residency at the University of Montreal and the Iowa University Hospitals and Clinics. Dr. Powell is co-founder of the Multidisciplinary Vascular Anomalies Team at CHU Sainte-Justine. She is a member of the scientific committee of the International Society for the Study of Vascular Anomalies (ISSVA). She is also the current President of the CDA.

Dr. Marta Rendon, board-certified dermatologist, is the founder of the Rendon Center for Dermatology & Aesthetic Medicine in Boca Raton, FL. She was a clinical associate professor for University of Miami School of Medicine in the Department of Dermatology. Dr. Rendon was a clinical associate professor at Florida Atlantic University Department of Biomedical Sciences in Boca Raton, FL, which is an affiliate of the University of Miami School of Medicine.

She is a respected researcher, who specializes in alpha-hydroxy acids, psoriasis, eczema, and how cosmetics affect the skin. Her special interests include phototherapy (treatment with ultraviolet light), dermatologic conditions resulting from systemic disease, cosmetic dermatology, dermatologic surgery, care of wounds, and laser surgery. She also specializes in the development of treatment options for pigmentary disorders, which are often experienced by dark skinned patients.

Dr. Rendon founded Skin Care Research, an organization specializing in the development of FDA regulated trials.

An accomplished author, published in many respected, peer-reviewed medical journals. Her exceptional skills and uncompromising dedication to patient care have led Dr. Marta Rendon to achieve local, national, and worldwide recognition as an expert dermatologic specialist.

Dr. Pegah Shahriaree, is a practicing Internist and a lecturer at the Department of Medicine at the University of Toronto. After she graduated from high school, she attended prestigious Shahid Beheshti Medical School in Tehran, where she graduated in 2000. She immigrated to Canada in 2002 with her family. As an International Medical graduate (IMG), she had to go through recertification and qualification examinations. Within 10 months, she started her medical training in Canada.

She has completed both residency trainings in Family Medicine and Internal Medicine, followed by a fellowship in Internal Medicine all at University of Toronto, where she is currently teaching and supervising medical trainees. She is an art lover, a painter, a mother and a lifelong learner who has just picked up cello and is learning it passionately.

Neil Shear is Head of Dermatology at Sunnybrook Hospital, University of Toronto. He is President-Elect of the Canadian Dermatology Association, and Past President of the Canadian Dermatology Foundation.

His interests range from hidradenitis to camouflage cosmetics. He is particularly proud of the Advanced Medical Dermatology Fellowship at Sunnybrook Dermatology and the great mentorship and leadership program, which has been 90% women.

Upon receiving his MD (Honours) from the University of Alberta, Dr. Zloty completed specialty training in dermatology at the University of British Columbia in 1994, followed by a fellowship in Mohs Surgery at the Oregon Health Sciences University in Portland in 1995. As an experienced Mohs surgeon, his practice for 23 years has been restricted to skin cancer surgery and cutaneous rejuvenation. A respected expert in his discipline, Dr. Zloty lectures frequently at both national and international meetings.

Holding 33 publications, Dr. Zloty is committed to improving and expanding current skin cancer and reconstructive surgical techniques. He is Clinical Professor and Director of Surgical Education in the Department of Dermatology and Skin Science at the University of British Columbia, in addition to Medical Director of the Dermatologic Surgery Centre at Vancouver General Hospital. Dr. Zloty has also served as President of the Canadian Dermatology Association, and on the Board of Directors for the American College of Mohs Surgery.